Obagi Medical Products, Inc (NASDAQ: OMPI) entered into a definitive merger agreement with Valeant Pharmaceuticals International, Inc. (NYSE: VRX) under ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE